These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 10722505)

  • 21. Efficacy of CS-834 against experimental pneumonia caused by penicillin-susceptible and -resistant Streptococcus pneumoniae in mice.
    Fukuoka T; Kawada H; Kitayama A; Koga T; Kubota M; Harasaki T; Kamai Y; Ohya S; Yasuda H; Iwata M; Kuwahara S
    Antimicrob Agents Chemother; 1998 Jan; 42(1):23-7. PubMed ID: 9449255
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [In vitro and in vivo activities of panipenem against penicillin-resistant Streptococcus pneumoniae].
    Fukuoka T; Inoue H; Abe T; Ohya S
    Jpn J Antibiot; 2001 Jul; 54(7):365-71. PubMed ID: 11560055
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of trovafloxacin against penicillin-susceptible and multiresistant strains of Streptococcus pneumoniae in a mouse pneumonia model.
    Bédos JP; Rieux V; Bauchet J; Muffat-Joly M; Carbon C; Azoulay-Dupuis E
    Antimicrob Agents Chemother; 1998 Apr; 42(4):862-7. PubMed ID: 9559797
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antimicrobial activity of SCH27899 (Ziracin), a novel everninomicin derivative, tested against Streptococcus spp.: disk diffusion/etest method evaluations and quality control guidelines. The Quality Control Study Group.
    Marshall SA; Jones RN; Erwin ME
    Diagn Microbiol Infect Dis; 1999 Jan; 33(1):19-25. PubMed ID: 9990471
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rifampicin+ceftriaxone versus vancomycin+ceftriaxone in the treatment of penicillin- and cephalosporin-resistant pneumococcal meningitis in an experimental rabbit model.
    Suntur BM; Yurtseven T; Sipahi OR; Buke C; Buke M
    Int J Antimicrob Agents; 2005 Sep; 26(3):258-60. PubMed ID: 16099624
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of a new parenteral oligosaccharide antibiotic, SCH27899 (Ziracin), in healthy subjects.
    Kozawa O; Uematsu T; Matsuno H; Niwa M; Kohno K; Kawato A; Takahashi K; Nagashima S; Kanamaru M
    Antimicrob Agents Chemother; 2001 Mar; 45(3):917-21. PubMed ID: 11181380
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacodynamic assessment of clarithromycin in a murine model of pneumococcal pneumonia.
    Tessier PR; Kim MK; Zhou W; Xuan D; Li C; Ye M; Nightingale CH; Nicolau DP
    Antimicrob Agents Chemother; 2002 May; 46(5):1425-34. PubMed ID: 11959578
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of the activity of ceftaroline against clinical isolates of penicillin-intermediate and penicillin-resistant Streptococcus pneumoniae with elevated MICs of ceftaroline using an in vitro pharmacodynamic model.
    Zhanel GG; Yachison C; Nichol K; Adam H; Noreddin AM; Hoban DJ; Karlowsky JA
    J Antimicrob Chemother; 2012 Jul; 67(7):1706-11. PubMed ID: 22467630
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Experimental lobar pneumonia due to penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae in immunocompetent and neutropenic rats: efficacy of penicillin and teicoplanin treatment.
    Candiani G; Abbondi M; Borgonovi M; Williams R
    J Antimicrob Chemother; 1997 Feb; 39(2):199-207. PubMed ID: 9069540
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Meropenem alone and in combination with vancomycin in experimental meningitis caused by a penicillin-resistant pneumococcal strain.
    Gerber CM; Cottagnoud M; Neftel KA; Täuber MG; Cottagnoud P
    Eur J Clin Microbiol Infect Dis; 1999 Dec; 18(12):866-70. PubMed ID: 10691197
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antimicrobial therapy of experimental meningitis caused by Streptococcus pneumoniae strains with different susceptibilities to penicillin.
    McCracken GH; Sakata Y
    Antimicrob Agents Chemother; 1985 Feb; 27(2):141-5. PubMed ID: 3845793
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative In Vivo Efficacies of Tedizolid in Neutropenic versus Immunocompetent Murine Streptococcus pneumoniae Lung Infection Models.
    Abdelraouf K; Nicolau DP
    Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27799200
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative study of treatment with penicillin, ceftriaxone, trovafloxacin, quinupristin-dalfopristin and vancomycin in experimental endocarditis due to penicillin- and ceftriaxone-resistant Streptococcus pneumoniae.
    López Fornas F; Martínez García F; Pérez Salmeron J; Roldán Conesa D; Cortés Sanchez R; García Alberola A; Ruíz Gómez J; Gómez Gómez J; Valdés Chávarri M
    J Antimicrob Chemother; 2001 May; 47(5):623-9. PubMed ID: 11328774
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pneumococcal infection in children: rational antibiotic choice for drug-resistant Streptococcus pneumoniae.
    Chiou CC; Hseih KS
    Acta Paediatr Taiwan; 2003; 44(2):67-74. PubMed ID: 12845845
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic options for pneumococcal pneumonia in Turkey.
    Oncu S; Erdem H; Pahsa A
    Clin Ther; 2005 Jun; 27(6):674-83. PubMed ID: 16117975
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of a novel tetracycline derivative, glycylcycline, against penicillin-resistant Streptococcus pneumoniae in a mouse model of pneumonia.
    Murakami K; Tateda K; Matsumoto T; Miyazaki S; Yamaguchi K
    J Antimicrob Chemother; 2000 Oct; 46(4):629-32. PubMed ID: 11020264
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impredictable susceptibility for cephalosporins in penicillin resistant Streptococcus pneumoniae.
    Verhaegen J; Vandeven J; Verbiest N; Fossion M; Mengeot PM; Amougou M; Verbist L
    Acta Clin Belg; 1997; 52(2):116-7. PubMed ID: 9204588
    [No Abstract]   [Full Text] [Related]  

  • 38. Bactericidal activities of parenteral antibiotics and genotype of penicillin-binding protein in Streptococcus pneumoniae and Haemophilus influenzae isolated from children's blood.
    Sakata H
    J Infect Chemother; 2006 Oct; 12(5):338-42. PubMed ID: 17109098
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacologic and bacteriologic properties of SCH-27899 (Ziracin), an investigational antibiotic from the everninomicin family.
    Foster DR; Rybak MJ
    Pharmacotherapy; 1999 Oct; 19(10):1111-7. PubMed ID: 10512059
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The importance of pharmacodynamic properties in treatment of penicillin resistant Streptococcus pneumoniae.
    Knudsen JD
    Dan Med Bull; 2000 Nov; 47(5):313-27. PubMed ID: 11155659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.